Lipid Panel Testing Market Report 2026

Lipid Panel Testing Market Overview

• Lipid Panel Testing market size has reached to $11.61 billion in 2025 • Expected to grow to $17.79 billion in 2030 at a compound annual growth rate (CAGR) of 9% • Growth Driver: The Rise in Cardiovascular and Diabetic Diseases Fueling the Growth of the Market Due to Increasing Need for Early Lipid Risk Detection • Market Trend: Roche Introduces Innovative Lipoprotein A Assay to Improve Cardiovascular Risk Assessment • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Lipid Panel Testing Market?

Lipid panel testing to a blood test that measuring the levels of various lipids or fats in the blood. It is used to assess a person's risk of developing cardiovascular disease. The main lipid panel testing product and services are devices, kits, and services. Devices, such as analyzer machines, refer to the equipment used to perform lipid panel testing. The various prescription modes are prescription-based testing, and OTC-based testing applied in hyperlipidemia, hypertriglyceridemia, familial hypercholesterolemia, hypo-lipoproteinemia, tangier disease, atherosclerosis, and others. The various end users are hospital, specialty clinics and physician offices, pathology laboratories, diagnostic clinics, ambulatory surgical centers, reference laboratories, academic and research institutes, and others.

What Is The Lipid Panel Testing Market Growth Forecast?

The lipid panel testing market size is expected to see strong growth in the next few years. It will grow to $17.79 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to increasing focus on preventive healthcare, rising demand for home diagnostics, integration of digital health platforms, growing use of AI-assisted diagnostic interpretation, expansion of population health screening initiatives. Major trends in the forecast period include increasing adoption of point-of-care lipid testing, rising use of automated lipid analyzers, growing demand for preventive cardiovascular screening, expansion of home-based lipid testing kits, enhanced focus on early risk assessment.

Global Lipid Panel Testing Market Segmentation

1) By Product And Services: Devices, Kits, Services 2) By Prescription Mode: Prescription-Based Testing, OTC-Based Testing 3) By Application: Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hypo-Lipoproteinemia, Tangier Disease, Atherosclerosis, Other Applications 4) By End User: Hospital, Specialty Clinics And Physician Offices, Pathology Laboratories, Diagnostic Clinics, Reference Laboratories, Academic And Research Institutes, Other End-Users Subsegments: 1) By Devices: Automated Analyzers, Point-Of-Care Testing Devices, Spectrophotometers 2) By Kits: Test Kits For Cholesterol, HDL And LDL Kits, Triglyceride Test Kits 3) By Services: Laboratory Testing Services, Diagnostic Services, Health Screening Services

What Is The Driver Of The Lipid Panel Testing Market?

The rising prevalence of cardiovascular and diabetic diseases is expected to propel the growth of the lipid panel testing market going forward. Cardiovascular diseases refer to a group of disorders affecting the heart and blood vessels, while diabetes is a chronic metabolic condition characterized by elevated blood glucose levels. Both conditions significantly increase lipid abnormalities, making lipid testing essential for early detection, risk stratification, treatment planning, and long-term monitoring. Lipid panel testing helps clinicians identify dyslipidemia, guide therapeutic interventions, and reduce the risk of complications such as heart attack and stroke. For instance, in September 2025, according to the American College of Cardiology (ACC), a US-based nonprofit medical association, global cardiovascular disease deaths reached $ 0.0192 billion (19.2 million) in 2023. Therefore, the rising burden of cardiovascular and diabetic diseases is driving the growth of the lipid panel testing industry.

Key Players In The Global Lipid Panel Testing Market

Major companies operating in the lipid panel testing market are Abbott Laboratories, Beckman Coulter Inc., F. Hoffmann-La Roche Ltd., Randox Laboratories Ltd., Thermo Fisher Scientific Inc., PTS Diagnostics, Quest Diagnostics Incorporated, Alere Inc., Boston Heart Diagnostics Corporation, Eurofins Scientific SE, Spark Diagnostics Pvt Ltd., Everlywell Inc., Horiba ABX SAS, Siemens Healthcare GmbH, Nova Biomedical Corporation, Bio-Rad Laboratories Inc., Danaher Corporation, DiaSorin S.p.A., EKF Diagnostics Holdings plc, Ortho Clinical Diagnostics LLC

Global Lipid Panel Testing Market Trends and Insights

Major companies operating in the lipid panel testing market are focusing on developing advanced solutions, such as Lp(a)-based diagnostic assays, to enhance cardiovascular risk assessment. An Lp(a)-based assay refers to a medical test that measures the level of lipoprotein(a) in the blood, enabling clinicians to identify individuals at elevated risk of cardiovascular diseases and provide personalized treatment recommendations. For instance, in May 2024, F. Hoffmann-La Roche AG, a Switzerland-based biotechnology and diagnostics company, launched the Tina-quant Lp(a) RxDx assay after receiving FDA Breakthrough Device Designation. This innovation measures the number of Lp(a) molecules per litre in a person’s bloodstream, offering a standardized and actionable biomarker for cardiovascular risk. Integrated into Roche’s existing serum work area (SWA) systems and cobas® platforms, it allows healthcare professionals to make informed decisions regarding Lp(a)-lowering therapies, improving patient outcomes and supporting precision cardiovascular care. The assay simplifies Lp(a) testing, increases diagnostic accuracy, and paves the way for wider adoption of personalized lipid management strategies.

What Are Latest Mergers And Acquisitions In The Lipid Panel Testing Market?

In July 2024, Hydreight Technologies Inc., a US-based provider of at-home blood testing solutions, formed a partnership with a National Laboratory. This partnership aims to expand Hydreight’s at-home testing capabilities by offering a wider range of laboratory tests across all fifty states in the United States, improving accessibility, convenience, and turnaround times for patients. National Laboratory is a US-based provider of clinical laboratory testing services, specializing in comprehensive diagnostic analyses and reporting for healthcare providers and consumers.

Regional Outlook

North America was the largest region in the lipid panel testing market in 2025. Asia-Pacific is expected to be the fastest growing region in the global lipid panel testing market during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Lipid Panel Testing Market?

The lipid panel testing market consists of revenues earned by entities by providing high cholesterol testing and lipoprotein analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The lipid panel testing market also includes sales of cholesterol test kit, lipid profile analyzer, and cholesterol self-test kit which are used in providing testing services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.